Combination of the toll like receptor agonist and α-Galactosylceramide as an efficient adjuvant for cancer vaccine

BACKGROUND: DNA vaccines have emerged as an attractive approach for the generation of cytotoxic T lymphocytes (CTL). In our previous study, we found That Toll like receptor (TLR) ligands are promising candidates for the development of novel adjuvants for DNA vaccine. To improve the efficacy of DNA v...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:J Biomed Sci
Hauptverfasser: Gableh, Fateme, Saeidi, Mohsen, Hemati, Shaghayegh, Hamdi, Kasra, Soleimanjahi, Hoorieh, Gorji, Ali, Ghaemi, Amir
Format: Artigo
Sprache:Inglês
Veröffentlicht: BioMed Central 2016
Schlagworte:
Research
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC4727273/
https://ncbi.nlm.nih.gov/pubmed/26811064
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12929-016-0238-3
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge